Lung cancer cell-derived exosomes containing EGFR or other TAAs have been demonstrated to also inhibit the function of CD-positive T cells with anti-tumor functions, thereby promoting the growth of lung cancer and interfering with anti-tumor immunotherapies [21,26]. The gene discussed is EGFR; the disease is lung carcinoma.